Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/22/24
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 08/30/22
End: 11/01/23
Due: 11/01/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis | NCT06191042 | selectION Therapeutics GmbH | user2@example.com | None | 2024-01-22 | 2025-07-31 | 2026-07-31 | - | - | 2025-07-14 |
| A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic Dermatitis | NCT05383378 | selectION Therapeutics GmbH | user2@example.com | None | 2022-08-30 | 2023-11-01 | 2024-11-01 | - | - | 2025-07-14 |